Key facts
- This page summarizes Joanna Xuqiong Wu's Form 3 filing for NovaBridge Biosciences (NBP).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 21:39.
Joanna Xuqiong Wu - 18 Mar 2026 Form 3 Insider Report for NovaBridge Biosciences (NBP)
- Reporting relationship
- Officer
- Issuer ticker
- NBP
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Xi-Yong (Sean) Fu as attorney-in-fact_
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Joanna Xuqiong Wu filed Form 3 for NovaBridge Biosciences (NBP) on 18 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002113843
Primary reporting owner
Wu Joanna Xuqiong
- Relationship
- Officer
- Address
- C/O NOVABRIDGE BIOSCIENCES,, 2440 RESEARCH BOULEVARD, SUITE 400, ROCKVILLE
- Signature
- /s/ Xi-Yong (Sean) Fu as attorney-in-fact_
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NBP
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,150
- Date
- 18 Mar 2026
- Ownership
- Direct
- Footnotes
- F1, F2
NBP
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,600
- Date
- 18 Mar 2026
- Ownership
- Spouse
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NBP
holding
Derivative
2026 Employee Share Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 46,875
- Exercise price
- $3.31
- Footnotes
- F1, F4, F5
NBP
holding
Derivative
Restricted Share Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 24,169
- Exercise price
- Footnotes
- F1, F4, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.
Footnote F2
Reported securities are represented by 500 ADSs.
Footnote F3
Reported securities are represented by 2,000 ADSs.
Footnote F4
Number of underlying securities and exercise price expressed in terms of ADSs.
Footnote F5
The option was granted on February 1, 2026. The option vests and becomes exercisable over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the first day of each third month.
Footnote F6
On February 1, 2026, the Reporting Person was granted 24,169 restricted share units ("RSUs"). Each RSU represents a contingent right to receive one ADS. The RSUs vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the first day of each third month.
SEC remarks
Senior Vice President, Head of Operations, General Counsel (US) Exhibit List: Ex. 24.1 - Power of Attorney